Recent research shows that preventing RSV in newborns can prevent asthma. RSV infection early in life can raise long-term asthma risk. The effect is strongest in children with genetic allergy risks. Early RSV infections also push the immune system to overreact to allergens.
Newborns who receive preventative RSV medication develop asthma less often. These findings show another benefit of early RSV protection. They also highlight the importance of inoculating young children. Protecting newborns may reduce severe asthma across communities.
Researchers from Belgium and Denmark conducted this large study together. Teams from V.I.P. and Ghent University collaborated with Danish scientists. They published their results in Science Immunology. Their work addresses a major health burden.
Asthma affects 5–15% of European children today. This long-term illness harms daily well-being and family life. It also creates heavy financial strain for health systems. These challenges have pushed experts to pursue new prevention strategies.





